Skip to content
Thursday, January 29, 2026

  • About the Jewish Review
  • Advertise
  • Contact Us
  • Home
  • Opt-out preferences
  • Terms of Use

Tag: Ranking

Teva back in top pharmaceutical rankings

April 16, 2024April 16, 2024David Rutman

After years of financial problems, downsizing, and dismissals, Israel’s multinational Teva Pharmaceutical Industries Ltd. has been named No. 19 among the top 20 best-earning pharmaceutical companies in the world. In 2022, Teva had revenues of $14.9 billion, which rose to $15.8b. last year. It has long specialized in generic drugs, but it has had some […]

Continue Reading

Recent Posts

  • Italian rapper Ghali’s planned Winter Olympics set draws backlash over his Gaza advocacy January 29, 2026
  • TikTok deal fuels rise of UpScrolled, whose founder conceived it as a haven for Palestinian activism January 29, 2026
  • The Return Of Ran Gvili January 29, 2026
  • Father of former Israeli hostage joins Columbia as a Jewish history professor January 28, 2026
  • Conservative British pro-Israel commentator Douglas Murray joins Yeshiva University January 28, 2026
  • Netanyahu alleges that Israeli soldiers died because US arms ’embargo’ meant they ‘didn’t have enough ammunition’ January 28, 2026

Categories

  • Business
  • Culture
  • Israel
  • Local
  • Opinion
  • Science and Health
  • Uncategorized
  • World News
News Vibrant | Theme: News Vibrant by CodeVibrant.